Mix n' Match: Buy any 3+ Lonza Products and Save 20% Featuring Lonza BulletKits™
Clonetics™ is the pioneer of human primary cells. In 1984, the company was the first to develop a novel technology which allowed culturing of human primary cells outside of their tissue origin. This was a crucial step forward in the research community as scientists now had the capacity to study tissue specific characteristics on a cellular level in vitro and develop more biologically relevant models. Lonza’s Clonetics™, by far, is the largest primary cells portfolio being offered commercially.